You are here

  • Home
  • Archive
  • Volume 79, Issue 4
  • Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trial

Article info

Article menu

This article has a correction. Please see:

XML
Rheumatoid arthritis
Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trial

Authors

  • Paul Emery Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK PubMed articlesGoogle scholar articles
  • Sarah Horton Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK Central Lancashire Moving Well Service, Lancashire and South Cumbria NHS Foundation Trust, Preston, UK PubMed articlesGoogle scholar articles
  • Raluca Bianca Dumitru Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK PubMed articlesGoogle scholar articles
  • Kamran Naraghi Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK PubMed articlesGoogle scholar articles
  • Désirée van der Heijde Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands PubMed articlesGoogle scholar articles
  • Richard J Wakefield Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK PubMed articlesGoogle scholar articles
  • Elizabeth M A Hensor Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK PubMed articlesGoogle scholar articles
  • Maya H Buch Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK Centre for Musculoskeletal Research, School of Biological Sciences, Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK NIHR Manchester Biomedical Research Centre, Manchester Academic Health Science Centre, Manchester University Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Maya H Buch, Centre for Musculoskeletal Research, School of Biological Sciences, AV Hill Building, University of Manchester, Manchester, Manchester M13 9LJ, UK; maya.buch{at}manchester.ac.uk
View Full Text

Citation

Emery P, Horton S, Dumitru RB, et al
Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trial
Annals of the Rheumatic Diseases 2020;79:464-471.

Publication history

  • Received October 25, 2019
  • Revised January 9, 2020
  • Accepted January 9, 2020
  • First published January 29, 2020.
Online issue publication 
March 06, 2023

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.